Production (Stage)
Evolutionary Genomics, Inc.
FNAM
$0.0002
-$0.0006-75.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 577.10K | 765.60K | 897.80K | 1.04M | 214.00K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 43.80K | 11.70K | 26.50K | 41.80K | 41.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 78.00K | -- | -- | -- | -- |
| Total Current Assets | 698.90K | 777.20K | 924.20K | 1.08M | 255.80K |
|
|
|||||
| Total Current Assets | 698.90K | 777.20K | 924.20K | 1.08M | 255.80K |
| Net Property, Plant & Equipment | 4.00K | 7.60K | 11.30K | 15.00K | 18.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.65M | 1.90M | 2.15M | 2.41M | 2.66M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.35M | 2.69M | 3.09M | 3.51M | 2.93M |
|
|
|||||
| Total Accounts Payable | 178.20K | 158.50K | 93.80K | 56.10K | 18.90K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 178.20K | 158.50K | 93.80K | 56.10K | 18.90K |
|
|
|||||
| Total Current Liabilities | 178.20K | 158.50K | 93.80K | 56.10K | 18.90K |
| Long-Term Debt | 3.74M | 3.74M | 3.74M | 3.74M | 3.74M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.92M | 3.90M | 3.84M | 3.80M | 3.76M |
|
|
|||||
| Common Stock & APIC | 12.39M | 12.49M | 12.49M | 12.49M | 11.96M |
| Retained Earnings | -19.81M | -19.48M | -18.93M | -18.40M | -17.88M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -7.43M | -6.99M | -6.44M | -5.91M | -5.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 4.02M | 4.02M | 4.02M | 4.02M | 3.57M |
| Preferred Stock, Others | 1.84M | 1.75M | 1.67M | 1.59M | 1.52M |
| Total Preferred Equity | 5.86M | 5.78M | 5.70M | 5.62M | 5.09M |
|
|
|||||
| Total Common Equity | -7.43M | -6.99M | -6.44M | -5.91M | -5.92M |
| Total Preferred Equity | 5.86M | 5.78M | 5.70M | 5.62M | 5.09M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.57M | -1.21M | -747.80K | -294.90K | -830.50K |
|
|
|||||